Physician profile
William L Lear
NPI 1467566216
$672.29
in general payments reported to CMS, 2019-2025
17 companies · $57.58 in 2025
The $57.58 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2021: $56.63 · 2022: $163 · 2023: $114 · 2024: $116 · 2025: $57.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $140.65 | 2022-2024 | Nexplanon |
| Pfizer INC. | $99.56 | 2019-2022 | |
| Exeltis, USA INC. | $54.28 | 2022-2024 | Slynd |
| Astellas Pharma US INC | $50.25 | 2023-2025 | Veozah |
| Intuitive Surgical, INC. | $50.00 | 2022 | |
| Abbvie INC. | $47.29 | 2019 | |
| Duchesnay USA Incorporated | $39.17 | 2019 | |
| Millicent US INC | $27.98 | 2025 | Femlyv, Intrarosa |
| Hologic Sales and Service, LLC | $23.93 | 2024 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $22.26 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.81 | 2022 | |
| Evofem Biosciences, INC. | $18.66 | 2021 | |
| Merck Sharp & Dohme LLC | $18.15 | 2019 | |
| Amgen INC. | $17.81 | 2023 | Evenity, Prolia |
| Shield Therapeutics INC | $17.27 | 2023 | Accrufer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $12.30 | 2022 | |
| Coopersurgical, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.